Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those...
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
Researchers evaluated improvements in predicting 5-year AF risk when adding novel candidate variables identified by machine learning to the CHARGE-AF Enriched score. Lead researcher Joshua Bundy, PhD, MPH,...
